BioSpace News Archive

Theratechnologies Inc. today announced that Mr. Paul Lévesque, President and Chief Executive Officer, will participate in a panel presentation at the Cantor Fitzgerald Global Healthcare Conference 2023 being held September 26-28 in New York City.

The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), has recently been designated as an International Atomic Energy Agency (IAEA) Collaborating Centre for Research and Development of Accelerator Science and Multidisciplinary Applications.

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage company developing targeted immunotherapeutic drugs, announced data from two radiolabeling studies that validate the tumor targeting attributes associated with albumin binding by the FHAB technology.

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that the United States Patent and Trademark Office (USPTO) has granted US Patent No. 11,759,431 for Nutriband’s proprietary AVERSA™ abuse deterrent technology utilizing taste aversion to address the primary routes of abuse of opioid based transdermal patches.

Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformation

Science 37 Holdings, Inc., the clinical research industry-leading Metasite™, announced that its Chief Delivery Officer, Darcy Forman, has been honored with a coveted spot on the prestigious PharmaVoice 100 list.

Corsair Pharma, Inc. today announced the closing of its $23M Series B financing led by New Rhein Healthcare Investors.

PROCEPT BioRobotics® Corporation, a surgical robotics company focused on developing transformative solutions in urology, proudly announces the grand opening of its state-of-the-art global corporate headquarters in San Jose, California.

Solid Biosciences Inc. today announced that Bo Cumbo, President and Chief Executive Officer, will participate in the following three upcoming investor conferences.

Lisata Therapeutics, Inc. announces that Gregory Berkin, Chief Information Officer at Lisata, will participate at InfoSec World 2023 being held September 25-27, 2023, in Lake Buena Vista, Florida.